NCT00099983 arm group 1b254de36c7b4ad95d5f7f02fce49ab6 [clinicaltrials_resource:NCT00099983/arm-group/1b254de36c7b4ad95d5f7f02fce49ab6]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00099983 arm group 1b254de36c7b4ad95d5f7f02fce49ab6 [clinicaltrials_resource:NCT00099983/arm-group/1b254de36c7b4ad95d5f7f02fce49ab6]
Bio2RDF identifier
NCT00099983/arm-group/1b254de36c7b4ad95d5f7f02fce49ab6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 254de36c7b4ad95d5f7f02fce49ab6
description [clinicaltrials_vocabulary:description]
1 mg/day tablet for week one, ...... ks at the target dose 3 mg/day
identifier
clinicaltrials_resource:NCT00099983/arm-group/1b254de36c7b4ad95d5f7f02fce49ab6
title
NCT00099983 arm group 1b254de36c7b4ad95d5f7f02fce49ab6
@en
type
label
NCT00099983 arm group 1b254de3 ...... 54de36c7b4ad95d5f7f02fce49ab6]
@en